Resolution Minerals Ltd (RLMLF) – Accelerating Development at the Horse Heaven Critical Minerals Project


Monday, May 04, 2026

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Exploration Momentum. Resolution Minerals continues to demonstrate strong exploration results across its Horse Heaven Project, confirming a large-scale, multi-commodity system. High-grade antimony at Antimony Ridge and extensive gold mineralization at Golden Gate highlight the project’s scale, with drilling confirming continuous mineralization that remains open in multiple directions. A major 13,700-meter Phase 2 drilling program is expected to commence this week to further define resource potential and support a maiden Mineral Resource Estimate targeted for Q1 2027.

Advancing Metallurgy and Development Pathways. Resolution is making significant progress in metallurgical testing and project development, particularly with tungsten and antimony processing. Test work has successfully produced high-grade tungsten concentrates and high-purity antimony products, demonstrating viable processing pathways and near-term production potential. Combined with the acquisition of processing infrastructure at Johnson Creek, these developments position the company to advance toward a vertically integrated, U.S.-based critical minerals platform.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

ACCO Brands (ACCO) – A Better Than Anticipated First Quarter


Monday, May 04, 2026

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Overview. ACCO Brands delivered a solid start to the year, with both sales and adjusted EPS coming in above management’s first-quarter expectations. Results reflected better-than-anticipated comparable sales and EPOS outperforming expectations. The first quarter benefited from favorable foreign exchange and the acquisition of EPOS, including a preliminary bargain purchase gain of $37.6 million.

1Q26 Results. Revenue of $343.7 million exceeded management’s $317-$327 million range and our $320 million estimate. Adjusted net income was $1.8 million, or $0.02/sh, better than the expected adjusted loss range of $0.06-0.03 per share. We had projected an adjusted loss of $6.7 million, or a loss of $0.07/sh.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Belden Bets $1.85 Billion on RUCKUS Networks to Become a Full-Stack IT/OT Powerhouse

Belden Inc. (NYSE: BDC) is making its biggest strategic push in years. The St. Louis-based specialty networking solutions provider announced Wednesday it has signed a definitive agreement to acquire RUCKUS Networks from Vistance Networks (Nasdaq: VISN) for approximately $1.85 billion in a debt-financed transaction that fundamentally reshapes what Belden is — and who it competes against.

The deal adds capabilities Belden simply doesn’t have today: enterprise-grade Wi-Fi and switching technology. For a company that has long been the infrastructure layer — the cables, connectors, and passive components behind enterprise and industrial networks — acquiring RUCKUS is a direct move up the stack.

What Belden Is Buying

RUCKUS is not a niche player. The company serves more than 48,000 customers globally with an integrated portfolio spanning Wi-Fi, enterprise switching, and an AI-driven cloud networking platform. Its sweet spots are high-density, mission-critical environments — hospitality, education, and healthcare — exactly the verticals where Belden already has customer relationships and distribution reach.

That overlap is the deal’s core thesis. Belden walks into existing customer accounts and can now offer a complete end-to-end networking solution rather than handing off business to competitors at the active networking layer. The cross-sell opportunity is immediate and doesn’t require building new channels from scratch.

The industrial angle is equally compelling. As manufacturers and industrial operators accelerate the convergence of their IT and OT environments — connecting factory floors to enterprise networks — demand for high-performance wireless and switching in industrial settings is rising sharply. RUCKUS gives Belden a proven platform to chase that opportunity.

The Financial Case

At approximately 13x projected 2026 adjusted EBITDA, Belden is paying a growth multiple, but the numbers justify the premium. RUCKUS comes in with high-single-digit revenue growth, gross margins above 60%, and adjusted EBITDA margins above 20% — all meaningfully better than Belden’s current profile. The transaction is expected to be immediately accretive to adjusted earnings per share and expand both gross and EBITDA margins in the first full year of ownership.

The combined adjusted EBITDA base is projected at approximately $650 million, which gives Belden a meaningful cash generation engine to attack the debt load. J.P. Morgan has provided fully committed debt financing, and Belden expects to bring net leverage below 3.0x within the first full year post-close, targeting approximately 1.5x by 2029. Share repurchases will be paused until leverage is closer to that long-term target — a responsible trade-off given the size of the bet.

The Bigger Picture

This acquisition is Belden making a definitive statement about what it wants to be. The company has spent years positioning around industrial and enterprise connectivity, but selling passive networking infrastructure in a world moving toward software-defined, cloud-managed networking was increasingly a commodity play. RUCKUS changes that equation.

Bringing an AI-driven cloud networking platform under the Belden umbrella alongside established hardware capabilities creates a more defensible, higher-value business. Customers increasingly want fewer vendors and more complete solutions — Belden is positioning itself to be that vendor.

Both boards have approved the transaction. Close is expected in the second half of 2026, pending regulatory approvals.

ARCHIMED to Take Esperion Therapeutics Private in Deal Valued at Up to $1.1 Billion

Esperion Therapeutics (Nasdaq: ESPR), the Ann Arbor-based commercial-stage biopharmaceutical company behind a growing portfolio of cardiometabolic therapies, is set to leave public markets after striking a definitive acquisition agreement with ARCHIMED, a Europe-headquartered healthcare-focused private equity firm with €9 billion in assets under management.

Under the terms of the deal announced May 1, 2026, Esperion shareholders will receive $3.16 per share in cash at closing — a 58% premium to the company’s closing share price on April 30 — along with one non-tradeable contingent value right (CVR) that entitles holders to participate in up to $100 million in additional milestone payments tied to future commercial performance. The total equity value of the transaction reaches approximately $1.1 billion on a fully diluted basis, assuming full achievement of those milestones.

The CVR Structure: Upside With Conditions

The contingent payment component is split into two tranches. The first is tied to annual U.S. net sales of bempedoic acid-containing products — primarily NEXLETOL and NEXLIZET — in calendar year 2027. Shareholders can receive up to $40 million in aggregate if those products surpass $350 million in annual sales, with a pro-rated payout if sales fall between $300 million and $350 million.

The second tranche is tied to ENBUMYST, Esperion’s bumetanide-based therapy, and pays out $60 million in aggregate if annual U.S. net sales hit or exceed $160 million in any single calendar year through December 31, 2030.

This CVR structure places meaningful commercial risk on post-close performance, particularly for ENBUMYST, which is the earlier-stage product of the two. Investors accepting the deal should weigh the probability of those sales thresholds being met before banking on the full $1.1 billion figure.

Why This Deal Makes Strategic Sense

Cardiovascular disease remains the leading cause of death globally, and the market for non-statin LDL-C lowering therapies has been steadily expanding. Esperion’s NEXLETOL and NEXLIZET have established commercial infrastructure in the U.S. and regulatory approvals in more than 40 countries, giving ARCHIMED a platform with real geographic reach and an active pipeline.

ARCHIMED’s exclusive focus on healthcare industries and its international network across Europe, North America, and Asia positions it to potentially accelerate Esperion’s international commercial strategy — something that can be difficult to execute efficiently inside a small-cap public company under the constraints of quarterly earnings pressure.

Deal Mechanics and Timeline

Debt financing for the acquisition is being provided by Pharmakon Advisors, LP, a specialized life sciences lender that has deployed up to $11 billion across 73 investments. The transaction carries no financing condition, which reduces deal risk meaningfully.

Esperion’s Board of Directors unanimously approved the deal and is recommending shareholder approval. The transaction is expected to close in the third quarter of 2026, pending shareholder vote and regulatory clearance. Moelis & Company is advising ARCHIMED, while Centerview Partners is advising Esperion.

Once the deal closes, Esperion will be delisted from Nasdaq and operate as a privately held company — removing a once-public cardiometabolic pure-play from the small-cap biotech universe.

Release – InPlay Oil Corp. Confirms Monthly Dividend for May 2026

InPlay Oil logo (CNW Group/InPlay Oil Corp.)

Research News and Market Data on IPOOF

InPlay Oil Corp. 

May 01, 2026, 07:30 ET

CALGARY, AB, April 30, 2026 /CNW/ – InPlay Oil Corp. (TSX: IPO) (OTCQX: IPOOF) (“InPlay” or the “Company”) is pleased to confirm that its Board of Directors has declared a monthly cash dividend of $0.09 per common share payable on May 29, 2026, to shareholders of record at the close of business on May 15, 2026. The monthly cash dividend is expected to be designated as an “eligible dividend” for Canadian federal and provincial income tax purposes.

About InPlay Oil Corp.
InPlay is a junior oil and gas exploration and production company with operations in Alberta focused on light oil production. The company operates long-lived, low-decline properties with drilling development and enhanced oil recovery potential as well as undeveloped lands with exploration possibilities. The common shares of InPlay trade on the Toronto Stock Exchange under the symbol IPO and the OTCQX Exchange under the symbol IPOOF.

SOURCE InPlay Oil Corp.

For further information please contact: Doug Bartole, President and Chief Executive Officer, InPlay Oil Corp., Telephone: (587) 955-0632, www.inplayoil.com; Darren Dittmer, Chief Financial Officer, InPlay Oil Corp., Telephone: (587) 955-0634

Release – The ONE Group Hospitality, Inc. to Host First Quarter 2026 Earnings Conference Call and Webcast at 4:30 PM ET on May 6, 2026

Research News and Market Data on STKS

 Download as PDF May 01, 2026

DENVER–(BUSINESS WIRE)– The ONE Group Hospitality, Inc. (“The ONE Group” or the “Company”) (Nasdaq: STKS) today announced that Emanuel “Manny” Hilario, President and Chief Executive Officer, and Nicole Thaung, Chief Financial Officer, will host a conference call and webcast to discuss first quarter 2026 financial results on Wednesday, May 6, 2026, at 4:30 PM ET. A press release containing the first quarter 2026 financial results will be issued after market close that same afternoon.

The conference call can be accessed live over the phone by dialing 201-389-0908. A replay will be available after the call and can be accessed by dialing 412-317-6671; the passcode is 13759769. The replay will be available until Wednesday, May 20, 2026.

The webcast can be accessed from the Investor Relations tab of The ONE Group’s website at http://www.togrp.com/ under “News / Events”.

About The ONE Group

The ONE Group Hospitality, Inc. (Nasdaq: STKS) is an international restaurant company that develops and operates upscale and polished casual, high-energy restaurants and lounges and provides hospitality management services for hotels, casinos and other high-end venues both in the U.S. and internationally. The ONE Group is recognized as one of “America’s Greatest Companies” (NEWSWEEK, 2025) and Benihana honored as Forbes Best Brands for Value. The ONE Group’s focus is to be the global leader in Vibe Dining, and its primary restaurant brands and operations are:

  • STK, a modern twist on the American steakhouse concept with restaurants in major metropolitan cities in the U.S., Europe and the Middle East, featuring premium steaks, seafood and specialty cocktails in an energetic upscale atmosphere.
  • Benihana, an interactive dining destination with highly skilled chefs preparing food right in front of guests and served in an energetic atmosphere alongside fresh sushi and innovative cocktails. The Company franchises Benihanas in the U.S., Caribbean, Central America, and South America.
  • Samurai, an interactive dining experience located in sunny Miami, FL, provides a distinctive dining experience where skilled personal chefs masterfully perform the ancient art of teppanyaki right before your eyes.
  • Kona Grill, a polished casual, bar-centric grill concept with restaurants in the U.S., featuring American favorites, award-winning sushi, and specialty cocktails in an upscale casual atmosphere.
  • Salt Water Social is your gateway to the seven seas, featuring an array of signature and unique fresh seafood items, complemented by the highest quality beef dishes and elegant, delicious cocktails.
  • Benihana Express, a small footprint casual concept showcasing the best of Benihana but without teppanyaki tables or bar.
  • RA Sushi, a Japanese cuisine concept that offers a fun-filled, bar-forward, upbeat, and vibrant dining atmosphere with restaurants in the U.S. anchored by creative sushi, inventive drinks, and outstanding service.
  • ONE Hospitality, The ONE Group’s food and beverage hospitality services business develops, manages and operates premier restaurants and turnkey food and beverage services within high-end hotels and casinos currently operating venues in the U.S. and Europe.

Additional information about The ONE Group can be found at www.togrp.com.

Investors:
ICR
Michelle Michalski or Raphael Gross
[email protected]

Media:
ICR
Judy Lee
[email protected]

Source: The ONE Group Hospitality, Inc.

Released May 1, 2026

Titan International (TWI) – A Solid Start to the Year


Friday, May 01, 2026

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Overview. Titan’s first quarter 2026 results came in at the high end of management’s expectations and above our projections, partly driven by positive forex. Titan achieved this performance against a macro backdrop that continues to be very dynamic. Once again, EMC was the star performer with revenue up 11.3% year-over-year and gross margin up 90 basis points. With a diversified portfolio of products, strategically positioned global plants, and a one-stop shop distribution channel, we believe Titan is well-positioned for today’s dynamic operating environment.

1Q26 Results. Revenue of $505 million was up 2.9% y-o-y and exceeded our $495 million projection. The revenue increase was driven by forex gains, which added approximately 3.7% to net sales growth. Gross margin improved to 14.1% from 14.0%. Adjusted EBITDA totaled $31.4 million, up from $30.8 million a year ago and our $26 million estimate. Titan reported adjusted EPS of breakeven versus adjusted EPS of $0.01 last year and our $0.03 estimate.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

NN (NNBR) – CARES Act Refund


Friday, May 01, 2026

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Refund. NN announced that the Company has been notified that its CARES Act refund has been processed for payment. The refund is in excess of $10 million. This refund has been a long time in coming, but will help the Company in its growth efforts, in our view.

Growth Opportunity. The tax refund will more than offset the $10 million the Company borrowed in 1Q26 to fund certain growth areas with both capital equipment and working capital. While it is too soon to say which path the Company will follow, the tax refund could enable to further boost the abundant growth opportunities through additional investment or repay the 1Q26 borrowing.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Euroseas (ESEA) – Fleet Expansion Strengthens Long-Term Earnings Visibility


Friday, May 01, 2026

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Euroseas expands its fleet. The company has ordered four additional feeder containerships, including two high-reefer vessels and two standard feeder ships, bringing its total newbuild program to ten vessels with a combined cost of about $500 million. Upon completion of the current newbuild program, Euroseas will operate 31 vessels with a total capacity of 93,834 twenty-foot equivalent units (TEU). The expansion reflects confidence in the feeder market and a deliberate focus on higher value cargo segments, particularly refrigerated goods, while also incorporating optionality for further fleet growth.

Strong earnings visibility. With a contracted revenue backlog of roughly $650 million and charter coverage extending beyond 2028, the company has secured a high level of earnings visibility. The current fleet is largely employed under time charter agreements at favorable rates, reducing exposure to market volatility and supporting stable cash flow generation to fund ongoing expansion.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Cadrenal Therapeutics (CVKD) – Preliminary Design For CAD-1005 Phase 3 In HIT Announced


Friday, May 01, 2026

Robert LeBoyer, Senior Vice President, Equity Research Analyst, Biotechnology, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Phase 3 Design Announced. Cadrenal held an end-of-Phase-2 meeting with the FDA to discuss the results of the CAD-1005 trial and receive guidance for the design of Phase 3. Following the receipt of the Meeting Minutes, the preliminary design for Phase 3 in HIT (Heparin-Induced Thrombocytopenia) has been announced. The trial is expected to begin in late FY2026 to early FY2027, with an NDA possible in FY2019.

HIT Is A Serious Condition. HIT is a potentially life-threatening immune reaction to heparin, an anticoagulant currently used in an estimated 12 million cardiac surgeries. HIT affects up to 5% of these patients, forming immune complexes that can activate platelets and cause excessive clotting. About 50% experience thrombosis, as well as embolisms, skin necrosis, and other cardiac events that can be fatal. CAD-1005 is a selective inhibitor of the 12-LOX immune pathway that causes HIT. This contrasts with other drugs that control symptoms and secondary morbidities following the immune response.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Banner Bank Moves to Absorb Bank of the Pacific in All-Stock Deal, Combined Entity to Hit $18 Billion in Assets

Banner Corporation (Nasdaq: BANR), the Walla Walla, Washington-based holding company for Banner Bank, has reached a definitive agreement to acquire Pacific Financial Corporation (OTCQX: PFLC), the parent of Bank of the Pacific, in an all-stock transaction valued at approximately $177 million. The deal, announced jointly by both companies, would push the combined institution to roughly $18 billion in total assets upon closing.

Deal Terms

Pacific Financial shareholders will receive 0.2633 shares of Banner common stock for each share of Pacific Financial they hold. Based on Banner’s April 29 closing price of $66.25, that translates to an implied value of $17.44 per Pacific Financial share. Following the close, Pacific Financial shareholders are expected to own approximately 7% of the combined company, with Banner’s existing shareholders holding the remaining 93%.

Banner has signaled the transaction is expected to be immediately accretive to 2027 earnings per share, excluding one-time transaction costs — a metric that will matter to BANR investors assessing dilution risk from the share issuance.

What Banner Is Getting

Bank of the Pacific brings 55 years of community banking history to the table. As of March 31, 2026, the Aberdeen, Washington-based institution carried $1.29 billion in assets, a $762 million loan portfolio, and — arguably most attractive to Banner — a $1.14 billion low-cost deposit base spread across 18 branches and offices in Western Washington and Northern Oregon.

That deposit quality is the real story here. In a rate environment where core deposit franchises command serious strategic value, Bank of the Pacific’s funding profile is precisely the kind of asset larger regional banks are hunting for. Low-cost deposits improve net interest margins and reduce reliance on more expensive wholesale funding — a meaningful operational benefit for Banner as it scales.

Geographic Logic

Banner Bank already operates across Washington, Oregon, Idaho, and California, giving it strong Pacific Northwest coverage. The Pacific Financial acquisition deepens penetration specifically in Western Washington and Western Oregon — coastal and rural markets where community banking relationships tend to be sticky and competition from money-center banks is less intense.

For Bank of the Pacific customers, the combination brings access to broader product offerings, higher commercial lending limits, and expanded branch infrastructure — the typical value proposition in community bank consolidation that tends to hold up in practice.

Leadership Continuity

One notable element of the deal structure: Denise Portmann, Bank of the Pacific’s President and CEO, is expected to join the Banner Bank executive team following close. Retaining acquired leadership, particularly in relationship-driven community banking, is a meaningful risk mitigant. It signals cultural alignment between the two institutions and helps protect client relationships during the transition period.

Timeline and Advisors

Both boards unanimously approved the transaction. Closing is targeted for the third quarter of 2026, pending Pacific Financial shareholder approval and regulatory clearance. Piper Sandler advised Pacific Financial, with Miller Nash LLP as legal counsel. BofA Securities advised Banner, with Ballard Spahr LLP handling legal.

This transaction is a clean example of the community bank consolidation trend that has been accelerating across the U.S. as smaller institutions face mounting pressure from technology costs, regulatory burden, and margin compression — dynamics that continue to favor scale.